Dupont Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-23,600
| Closed | -$3.9M | – | 2051 |
|
|
2021
Q2 | $3.9M | Sell |
23,600
-6,826
| -22% | -$1.14M | 0.09% | 190 |
|
|
2021
Q1 | $4.67M | Buy |
30,426
+22,557
| +287% | +$3.06M | 0.11% | 140 |
|
|
2020
Q4 | $987K | Sell |
7,869
-3,983
| -34% | -$445K | 0.02% | 573 |
|
|
2020
Q3 | $1.2M | Sell |
11,852
-1,639
| -12% | -$167K | 0.03% | 442 |
|
|
2020
Q2 | $1.31M | Buy |
13,491
+8,857
| +191% | +$824K | 0.03% | 423 |
|
|
2020
Q1 | $385K | Buy |
+4,634
| New | +$452K | 0.01% | 772 |
|
|
2019
Q3 | – | Sell |
-5,925
| Closed | -$587K | – | 1298 |
|
|
2019
Q2 | $587K | Hold |
5,925
| – | – | 0.01% | 711 |
|
|
2019
Q1 | $653K | Buy |
5,925
+581
| +11% | +$60.7K | 0.01% | 676 |
|
|
2018
Q4 | $491K | Sell |
5,344
-19,556
| -79% | -$1.98M | 0.01% | 738 |
|
|
2018
Q3 | $2.74M | Buy |
24,900
+21,290
| +590% | +$2.22M | 0.06% | 310 |
|
|
2018
Q2 | $337K | Sell |
3,610
-6,651
| -65% | -$573K | 0.01% | 800 |
|
|
2018
Q1 | $851K | Hold |
10,261
| – | – | 0.02% | 557 |
|
|
2017
Q4 | $934K | Buy |
+10,261
| New | +$854K | 0.02% | 530 |
|
|
2017
Q3 | – | Sell |
-17,892
| Closed | -$1.34M | – | 1005 |
|
|
2017
Q2 | $1.34M | Sell |
17,892
-42,108
| -70% | -$2.92M | 0.03% | 458 |
|
|
2017
Q1 | $3.91M | Buy |
+60,000
| New | +$3.53M | 0.09% | 220 |
|
Other funds holding PRAH
Dupont Capital Management's PRAH Position: Q3 2021 in Review
Dupont Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 23,600 shares — an estimated $3.9M sold.
Dupont Capital Management first reported a position in PRAH in Q1 2017 and held it in 15 quarters. The position peaked at $4.67M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Dupont Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Dupont Capital Management sold 23,600 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.9M.
- Dupont Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 15 quarters.
- Dupont Capital Management's PRA Health Sciences, Inc. position peaked at $4.67M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.